Dishman India
One of 10,000+ projects Taiyo tracks in India.
Source: International Finance Corporation (IFC)
Dishman Pharmaceuticals and Chemicals Ltd (“Dishman” or “the Company”) is one of the leading companies in India providing Contract Research and Contract Manufacturing Services (CRAMS). While CRAMS services account for over 75% of the company’s revenues, Dishman also sells pharmaceutical intermediates, APIs and catalysts in the generic market, amounting to 25% revenues. Over the next three years,
- Status
- Closed
- Sector
- Hospital, Manufacturing (Industrial), Government
- Location
- India
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Dishman India
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | completed |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Dishman Pharmaceuticals and Chemicals Ltd (“Dishman” or “the Company”) is one of the leading companies in India providing Contract Research and Contract Manufacturing Services (CRAMS). While CRAMS services account for over 75% of the company’s revenues, Dishman also sells pharmaceutical intermediates, APIs and catalysts in the generic market, amounting to 25% revenues. Over the next three years, Dishman is undertaking an investment program (“the Project”). This includes:Establishment of new facilities at an existing site in India, Investment in a manufacturing facility in Shanghai, China, and Investment in overseas subsidiaries and joint ventures, including Saudi Arabia. |
Original sector | FA - Pharmaceuticals and Medicine |
Location
Country | India |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Hospital, Manufacturing (Industrial), Government |
Article published date | 2026-01-18 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
